OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Transmission patterns of hepatitis E virus	99
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	96
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	86
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	74
Editorial Board	72
Inhaled aerosol viral-vectored vaccines against tuberculosis	66
The enigmatic roles of Anelloviridae and Redondoviridae in humans	62
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	61
Editorial Board	57
Human placental models for studying viral infections	50
Structural basis for neutralization of enterovirus	49
Virus–host protein interactions as footprints of human cytomegalovirus replication	49
Editorial overview: Viral pathogenesis	47
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	45
Emerging technologies in the study of the virome	43
New preventive strategies for respiratory syncytial virus infection in children	42
Recent progress in development of monoclonal antibodies against human cytomegalovirus	42
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	40
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	36
Editorial Board	36
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	33
Engineering therapeutic phages for enhanced antibacterial efficacy	32
Mitigation of evolved bacterial resistance to phage therapy	31
A complex immune communication between eicosanoids and pulmonary macrophages	30
Perspective on taxonomic classification of uncultivated viruses	30

The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	29
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	29
Platelets in the pathogenesis of flavivirus disease	29
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	28
Epigenetic control of the Epstein-Barr lifecycle	28
When good turns bad: how viruses exploit innate immunity factors	27
Human organoid models to study coronavirus infections of the respiratory tract	27
Asymmetry in icosahedral viruses	26
Editorial Board	26
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	26
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	25
Retasking of canonical antiviral factors into proviral effectors	25
Tissue-resident memory T cells in protective immunity to influenza virus	25
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	24
Oncogenic Animal Herpesviruses	24
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	23
Modeling zoonotic and vector-borne viruses	23
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	23
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	23
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	23
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	22
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	21
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	21
Immune responses to human respiratory coronaviruses infection in mouse models	21
Deimmunization of flagellin adjuvant for clinical application	21
Advances in human monoclonal antibody therapy for HBV infection	20
Antigenic evolution of SARS coronavirus 2	20
Editorial Board	17
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	17
Viral Z-RNA triggers ZBP1-dependent cell death	17
Broadly neutralizing antibodies against COVID-19	17
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	17
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales	16
Editorial Board	16
The dynamic interactome of microRNAs and the human papillomavirus in head and neck cancers	16
Early signaling pathways in virus-infected cells	16
Accumulation of host cell genetic errors following high-risk HPV infection	16
Editorial overview: Special issue on phage therapy	16
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	15
Structural insights into hepatitis C virus neutralization	15
Editorial overview: Viral immunology before COVID-19	15
Editorial overview: Engineering elimination of chronic viral hepatitis	15
How and why RNA genomes are (partially) ordered in viral capsids	15
Editorial overview: Virus structure and expression	14
Editorial overview: Special issue on virus structure and expression in current opinion in virology	14
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	14
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	14
Koala retrovirus and neoplasia: correlation and underlying mechanisms	13
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	13

European regulatory aspects of phage therapy: magistral phage preparations	13
The intestinal virome: lessons from animal models	13
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	13
Broad neutralizing antibody-based strategies to tackle influenza	13
Editorial Board	13
Lying low-chromatin insulation in persistent DNA virus infection	13
Phage therapy for secondary bacterial infections with COVID-19	13
Editorial Board	13
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	12
Therapeutic approaches to Epstein–Barr virus cancers	12
Editorial Board	12
Editorial Board	12
Virus structure and structure-based antivirals	12
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	12
Editorial overview: Viruses and cancer — challenges, breakthroughs, and future directions	12
The role of human lipoproteins for hepatitis C virus persistence	12
An overview of the current state of phage therapy for the treatment of biofilm-related infections	11
Zoonotic disease and virome diversity in bats	11
Ex vivo culture models to study viral infections of the liver	11
Endocytosis of Bacteriophages	11
Editorial Board	11
A comparative review of adenovirus A12 and C5 oncogenes	11
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	10
Co-opted membranes, lipids, and host proteins: what have we learned from tombusviruses?	10
Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection	10